Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar CNBCEli Lilly Stock Rises on Earnings and Boost to Guidance Barron'sLilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance Yahoo FinanceLilly Raises Guidance on Strength of Weight Loss, Obesity Drugs BloombergEli Lilly stock pops on raised full-year outlook (LLY:NYSE) Seeking Alpha